V-Square Quantitative Management’s Royalty Pharma RPRX Stock Holding History

V-Square Quantitative Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$253K	Buy	5,270 +141	+3%	+$6.17K	0.03%	491
2025 Q4	$198K	Buy	+5,129	New	+$196K	0.02%	513
2025 Q3	–	Sell	-4,618	Closed	-$166K	–	506
2025 Q2	$166K	Buy	+4,618	New	+$153K	0.02%	509

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

V-Square Quantitative Management's RPRX Position: Q1 2026 in Review

V-Square Quantitative Management increased its Royalty Pharma (RPRX) stake by 2.7% in Q1 2026, buying an estimated $6.17K and bringing the position to 5,270 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #491.

V-Square Quantitative Management first reported a position in RPRX in Q2 2025 and has held it in 3 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

V-Square Quantitative Management held 5,270 shares of Royalty Pharma worth $253K as of Q1 2026.
V-Square Quantitative Management bought 141 Royalty Pharma shares in Q1 2026, an estimated $6.17K.
Royalty Pharma made up 0.03% of V-Square Quantitative Management's portfolio in Q1 2026, its #491 holding.
V-Square Quantitative Management first reported a position in Royalty Pharma in Q2 2025 and has held it in 3 quarters since.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on V-Square Quantitative Management's 13F filing for Q1 2026, filed 27 Apr 2026.